Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal vs Oral Omeprazole in Infants with GERD
NCT00226044Phase 3Completed
- Sponsor
- Rijnstate
- Start
- Sep 2005
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Rijnstate. Started Sep 2005; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00226044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226044.